Nitrostat

SECTION 2: Hazards identification

Appearance: Round, white tablet

Signal word

WARNING

Hazard statements

Harmful if swallowed. Harmful if inhaled. Harmful in contact with skin.

Additional information

Short Term: Chest pain, acute myocardial infarction, and sudden death have occurred during temporary withdrawal of organic nitrates from industrial workers exposed for long periods of time. Known Clinical Effects: Headache, which may be severe and persistent, may occur immediately after use. Vertigo, dizziness, weakness, palpitation, and other manifestations of postural hypotension may develop occasionally. Flushing, drug rash, and exfoliative dermatitis have been reported in patients receiving nitrate therapy. EU Indication of danger: Harmful EU Hazard Symbols: EU Risk Phrases: R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.